Bone marrow dysfunction in chronic heart failure patients

European Journal of Heart Failure

Volumn 12, Issue 7, 2010, Pages 676-684

  Westenbrink, B Daan ^a   Voors, Adriaan A ^a   De Boer, Rudolf A ^a   Schuringa, Jan J ^a   Klinkenberg, Theo ^a   Van Der Harst, Pim ^a   Vellenga, Edo ^a   Van Veldhuisen, Dirk J ^a   Van Gilst, Wiek H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Anaemia; Bone marrow; Haematopoiesis; Heart failure

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; GROWTH FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 3; LOOP DIURETIC AGENT; MYELOID GROWTH FACTOR; RECOMBINANT ERYTHROPOIETIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANEMIA; APOPTOSIS; ARTICLE; BONE MARROW; BONE MARROW DEPRESSION; BURST FORMING UNIT E; CD34 SELECTION; CELL COUNT; CELL CULTURE; CELL DENSITY; CELL DIFFERENTIATION; CELL ISOLATION; CHEMICAL ANALYSIS; CLINICAL ARTICLE; CLONOGENESIS; COLONY FORMING UNIT GM; COLONY FORMING UNIT M; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DISEASE ASSOCIATION; DISEASE SEVERITY; ERYTHROID CELL; ERYTHROPOIESIS; FEMALE; FLOW CYTOMETRY; HEART FAILURE; HEART FUNCTION; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC SYSTEM; HUMAN; HUMAN CELL; MALE; MYELOID PROGENITOR CELL; MYELOPOIESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; CYTOLOGY; ERYTHROID PRECURSOR CELL; HEMATOPOIESIS; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY;

AGED; APOPTOSIS; BONE MARROW; CELL COUNT; CELL DIFFERENTIATION; ERYTHROID PRECURSOR CELLS; FEMALE; FLOW CYTOMETRY; GRANULOCYTE-MACROPHAGE PROGENITOR CELLS; HEART FAILURE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; MALE; MIDDLE AGED; RECEPTORS, ERYTHROPOIETIN;

EID: 77954932493     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfq061     Document Type: Article

References (23)

1. van der Meer P, Voors AA, Lipsic E, van Gilst WH, van Veldhuisen DJ. Erythro-poietin in cardiovascular diseases. Eur Heart J 2004;25:285-291.
2. Tang YD, Katz SD. Anaemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options. Circulation 2006;113:2454-2461.
3. Groenveld HF, Januzzi JL, Damman K, van Wijngaarden J, Hillege HL, van Veldhuisen DJ, van der Meer P. Anaemia and mortality in heart failure patients a systematic review and meta-analysis. J Am Coll Cardiol 2008;52:818-827.
4. Anand IS. Anaemia and chronic heart failure implications and treatment options. J Am Coll Cardiol 2008;52:501-511.
5. George J, Patal S, Wexler D, Abashidze A, Shmilovich H, Barak T, Sheps D, Keren G. Circulating erythropoietin levels and prognosis in patients with congestive heart failure: comparison with neurohormonal and inflammatory markers. Arch Intern Med 2005;165:1304-1309.
6. van der Meer P, Voors AA, Lipsic E, Smilde TD, van Gilst WH, van Veldhuisen DJ. Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure. J Am Coll Cardiol 2004;44:63-67.
7. Westenbrink BD, Visser FW, Voors AA, Smilde TD, Lipsic E, Navis G, Hillege HL, van Gilst WH, van Veldhuisen DJ. Anaemia in chronic heart failure is not only related to impaired renal perfusion and blunted erythropoietin production, but to fluid retention as well. Eur Heart J 2007;28:166-171.
8. van der Meer P, Lok DJ, Januzzi JL, de la Porte PW, Lipsic E, van Wijngaarden J, Voors AA, van Gilst WH, van Veldhuisen DJ. Adequacy of endogenous erythropoietin levels and mortality in anaemic heart failure patients. Eur Heart J 2008;29:1510-1515. 9.
9. Van der Meer P, Lipsic E, Westenbrink BD, van de Wal RM, Schoemaker RG, Vellenga E, van Veldhuisen DJ, Voors AA, van Gilst WH. Levels of Haematopoi-esis inhibitor N-acetyl-seryl-aspartyl-lysyl-proline partially explain the occurrence of anaemia in heart failure. Circulation 2005;112:1743-1747.
10. Voulgari PV, Kolios G, Papadopoulos GK, Katsaraki A, Seferiadis K, Drosos AA. Role of cytokines in the pathogenesis of anaemia of chronic disease in rheumatoid arthritis. Clin Immunol 1999;92:153-160.
11. Weiss G. Pathogenesis and treatment of anaemia of chronic disease. Blood Rev 2002;16:87-96.
12. Iversen PO, Woldbaek PR, Tonnessen T, Christensen G. Decreased haematopoi-esis in bone marrow of mice with congestive heart failure. Am J Physiol Regul Integr Comp Physiol 2002;282:R166-R172.
13. Pontikoglou C, Liapakis G, Pyrovolaki K, Papadakis M, Bux J, Eliopoulos GD, Papadaki HA. Evidence for downregulation of erythropoietin receptor in bone marrow erythroid cells of patients with chronic idiopathic neutropenia. Exp Hematol 2006;34:1312-1322. (Pubitemid 44374831)
14. Kissel CK, Lehmann R, Assmus B, Aicher A, Honold J, Fischer-Rasokat U, Heeschen C, Spyridopoulos I, Dimmeler S, Zeiher AM. Selective functional exhaustion of haematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure. J Am Coll Cardiol 2007;49:2341-11349
15. Vellenga E, de Wolf JT, Beentjes JA, Esselink MT, Smit JW, Halie MR. Divergent effects of interleukin-4 (IL-4 on the granulocyte colony-stimulating factor and IL-3-supported myeloid colony formation from normal and leukemic bone marrow cells. Blood 1990;75:633-637.
16. Papadaki HA, Kritikos HD, Gemetzi C, Koutala H, Marsh JC, Boumpas DT, Eliopoulos GD. Bone marrow progenitor cell reserve and function and stromal cell function are defective in rheumatoid arthritis: evidence for a tumor necrosis factor alpha-mediated effect. Blood 2002;99:1610-1619.
17. Spyridopoulos I, Erben Y, Brummendorf TH, Haendeler J, Dietz K, Seeger F, Kissel CK, Martin H, Hoffmann J, Assmus B, Zeiher AM, Dimmeler S. Telomere gap between granulocytes and lymphocytes is a determinant for haematopoetic progenitor cell impairment in patients with previous myocardial infarction. Arter-ioscler Thromb Vasc Biol 2008;28:968-974.
18. Schuller CE, Jankowski K, Mackenzie KL. Telomere length of cord blood-derived CD34+ progenitors predicts erythroid proliferative potential. Leukemia 2007;21: 983-991.
19. an der Harst P, van der Steege G, de Boer RA, Voors AA, Hall AS, Mulder MJ, van Gilst WH, van Veldhuisen DJ. Telomere length of circulating leukocytes is decreased in patients with chronic heart failure. J Am Coll Cardiol 2007;49:1459-1464.
20. Opasich C, Cazzola M, Scelsi L, De Feo S, Bosimini E, Lagioia R, Febo O, Ferrari R, Fucili A, Moratti R, Tramarin R, Tavazzi L. Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure. Eur Heart J 2005;26:2232-2237.
21. Androne AS, Katz SD, Lund L, LaManca J, Hudaihed A, Hryniewicz K, Mancini DM. Hemodilution is common in patients with advanced heart failure. Circulation 2003; 107:226-229.
22. Adlbrecht C, Kommata S, Hülsmann M, Szekeres T, Bieglmayer C, Strunk G, Karanikas G, Berger R, Mörtl D, Kletter K, Maurer G, Lang IM, Pacher R. Chronic heart failure leads to an expanded plasma volume and pseudoanaemia, but does not lead to a reduction in the body's red cell volume. Eur Heart J 2008;29:2343-2350.
23. Westenbrink BD, de Boer RA, Voors AA, van Gilst WH, van Veldhuisen DJ. Anaemia in chronic heart failure: etiology and treatment options. Curr Opin Cardiol 2008;23:141-147.